NEW YORK, September 28, 2015 /PRNewswire/ --
ACI Association has initiated research coverage on the following
equities: CBOE Holdings, Inc. (NASDAQ: CBOE),
Boston Private Financial Holdings, Inc. (NASDAQ: BPFH),
AEterna Zentaris Inc. (NASDAQ: AEZS), Great Basin
Scientific, Inc. (NASDAQ: GBSN), Gilead Sciences, Inc.
(NASDAQ: GILD). On Friday, September 25,
2015, Nasdaq ended at 4,686.50 down 1.01%, Dow Jones
advanced 0.70%, to finish the day at 16,314.67, and the S&P
closed at 1,931.34, down 0.05%. Register for your complimentary
reports at the links given below.
--
CBOE Holdings Inc.
--
CBOE Holdings Inc.'s stock edged higher by 0.36% to close
Friday's session at USD 66.40. The
company's shares oscillated between USD
65.94 and USD 67.03. The stock recorded a trading volume of
0.55 million shares, which was above its 50-day daily average
volume of 0.53 million shares and below its 52-week average volume
of 0.62 million shares. Over the last three days, CBOE Holdings
Inc.'s shares have advanced 1.93% and in the past one week it has
moved up 2.72%. Furthermore, over the last three months, the stock
has gained 15.88% and in the past six months, the shares have
picked up 15.54%. Further, the stock is trading at a price to
earnings ratio of 30.32 and a price to book ratio of 24.25. This
compares to a historical PE ratio of 28.75 and a historical PB
ratio close to 21.33. Sign up and read the free notes on CBOE at:
http://www.aciassociation.com/CBOE.pdf
--
Boston Private Financial Holdings Inc.
--
The stock of Boston Private Financial Holdings Inc. gained 0.34%
to close Friday's session at USD
11.84. The shares of the company moved in the range of
USD 11.83 and USD 12.00. A trading volume of 0.51 million
shares was recorded, which was lower than its 150-day daily average
volume of 0.52 million shares and below its 52-week average volume
of 0.55 million shares. Over the last five days, Boston Private
Financial Holdings Inc.'s shares have advanced 3.86% and in the
past one month, it has gained a momentum of 3.95%. Additionally,
over the last three months, the stock has declined 13.70% and in
the past six months, the shares have registered a loss of 2.47%.
Further, the stock is trading at a price to earnings ratio of 15.58
and a price to book ratio of 1.46. Register for free on ACI
Association and access the latest research on BPFH at:
http://www.aciassociation.com/BPFH.pdf
--
AEterna Zentaris Inc.
--
AEterna Zentaris Inc.'s stock increased by 3.65% to close
Friday's session at USD 0.09. The
company's shares fluctuated in the range of USD 0.08 and USD
0.10. A total of 23.46 million shares exchanged hands, which
surpassed its 50-day daily average volume of 18.42 million shares
and was above its 52-week average volume of 5.64 million shares.
Over the last three days AEterna Zentaris Inc.'s shares have
advanced 14.42% and in the past one week it has moved down 25.65%.
Furthermore, over the last three months, the stock has lost 68.55%
and in the past six months, the shares have shed 83.38%. The stock
is currently trading at a price to book ratio of 1.43, which
compares to a historical PB ratio close to 2.71. The complete
research on AEZS is available for free at:
http://www.aciassociation.com/AEZS.pdf
--
Great Basin Scientific Inc.
--
Great Basin Scientific Inc.'s stock slipped by 6.19% to close
Friday's session at USD 0.08. The
company's shares oscillated between USD 0.08
and USD 0.09. The stock recorded a trading volume of 16.69
million shares, which was above its 50-day daily average volume of
14.21 million shares and above its 52-week average volume of 3.39
million shares. Over the last five days, Great Basin Scientific
Inc.'s shares have advanced 61.00% and in the past one month, it
has lost 84.84%. In addition, over the last three months, the stock
has lost 97.31% and year to date, the shares have shed 96.61%. Free
in-depth research on GBSN is available at:
http://www.aciassociation.com/GBSN.pdf
--
Gilead Sciences Inc.
--
Gilead Sciences Inc.'s stock declined 2.31% to close Friday's
session at USD 100.14. The share
price vacillated between USD 99.19 and USD
104.19. The stock recorded a trading volume of 16.00 million
shares, which was above its 50-day daily average volume of 11.07
million shares and above its 52-week average volume of 13.10
million shares. Over the last three days Gilead Sciences Inc.'s
shares have declined by 5.98% and in the past one week it has moved
down 7.65%. Moreover, in the last six months, the stock has lost
0.85% and year to date, the shares have picked up 7.15%. Gilead
Sciences Inc. has a current dividend yield of 1.72%. Further, the
stock is trading at a price to earnings ratio of 10.51 and a price
to book ratio of 9.06. The complimentary notes on GILD can be
downloaded in PDF format at:
http://www.aciassociation.com/GILD.pdf
--
About ACI Association:
Active Charter Investors Association ("ACI Association")
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
equities listed on NYSE and NASDAQ and micro-cap stocks. ACI
Association has two distinct and independent departments. One
department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ACI Association has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein. The information in this release has been
sourced from a third party data base.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor
(collectively referred to as the "Publishers") are not responsible
for any error which may be occasioned at the time of printing of
this document or any error, mistake or shortcoming. No liability is
accepted by the Publishers whatsoever for any direct, indirect or
consequential loss arising from the use of this document. The
Publishers expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, the Publishers do not (1) guarantee the accuracy,
timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The
included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ACI Association nor any party affiliated
with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our
report(s), read our disclosures, or for more information, visit
http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.aciassociation.com